Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Sadoff

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Infection and Immunity|June 1, 1980
Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterizationD E Ohman, J C Sadoff, B H Iglewski
The Journal of Infectious Diseases|October 1, 1986
Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humansS J Cryz, J C Sadoff, E Fürer, et al.
Antibiotics and Chemotherapy|January 1, 1987
A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccineS J Cryz, E Fürer, J C Sadoff, et al.
Infection and Immunity|April 1, 1984
Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epitheliumR Ramphal, J C Sadoff, M Pyle, et al.
Infection and Immunity|April 1, 1986
Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccineS J Cryz, E Furer, J C Sadoff, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1988
Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccineS J Cryz, J C Sadoff, D Ohman, et al.
Antibiotics and Chemotherapy|January 1, 1989
Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humansS J Cryz, J C Sadoff, A S Cross, et al.
Infection and Immunity|July 1, 1993
Choice of bacteria in animal models of sepsisA S Cross, S M Opal, J C Sadoff, et al.
Infectious Disease Clinics of North America|June 1, 1990
Escherichia coli and Klebsiella vaccines and immunotherapyA S Cross, J C Sadoff, E Furer, et al.
Infection and Immunity|February 1, 1990
Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccinesS J Cryz, A S Cross, J C Sadoff, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Infection and Immunity|June 1, 1980
Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterizationD E Ohman, J C Sadoff, B H Iglewski
The Journal of Infectious Diseases|October 1, 1986
Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humansS J Cryz, J C Sadoff, E Fürer, et al.
Antibiotics and Chemotherapy|January 1, 1987
A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccineS J Cryz, E Fürer, J C Sadoff, et al.
Infection and Immunity|April 1, 1984
Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epitheliumR Ramphal, J C Sadoff, M Pyle, et al.
Infection and Immunity|April 1, 1986
Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccineS J Cryz, E Furer, J C Sadoff, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1988
Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccineS J Cryz, J C Sadoff, D Ohman, et al.
Antibiotics and Chemotherapy|January 1, 1989
Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humansS J Cryz, J C Sadoff, A S Cross, et al.
Infection and Immunity|July 1, 1993
Choice of bacteria in animal models of sepsisA S Cross, S M Opal, J C Sadoff, et al.
Infectious Disease Clinics of North America|June 1, 1990
Escherichia coli and Klebsiella vaccines and immunotherapyA S Cross, J C Sadoff, E Furer, et al.
Infection and Immunity|February 1, 1990
Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccinesS J Cryz, A S Cross, J C Sadoff, et al.
Pageof 12